Blue Clay Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q3
$587K Buy
32,390
+1,390
+4% +$25.2K 0.66% 28
2016
Q2
$511K Buy
+31,000
New +$511K 0.59% 38
2016
Q1
Hold
0
116
2015
Q4
Hold
0
110